Skip to content

The Efficacy of Progesterone in Treatment of Traumatic Optic Neuropathy.

The Efficacy of Progesterone in Treatment of Traumatic Optic Neuropathy.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20151118001
Enrollment
50
Registered
2015-11-18
Start date
2015-11-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic optic neuropathy Traumatic optic neuropathy

Interventions

Depot medroxyprogesterone acetate (DMPA) 1 mg/kg. intramuscular injection every 12 hrs. for 5 days,Review steroid treatment in the past,Observation
Experimental Drug,No Intervention Drug,No Intervention No treatment
Progesterone group,Steriod group,Observation group

Sponsors

Phramongkutkloa college of medicine
Lead Sponsor
Phramongkutkloa college of medicine
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male or female patient, aged 18-65 years old. 2. Diagnosed with indirect traumatic optic neuropathy within 7 days 3. No other ocular or visual pathway effecting visual function

Exclusion criteria

Exclusion criteria: 1. Low level of consciousness and unable to evaluated visual acuity 2. Other system injury such as cardiovascular, pulmonary injury 3. Progesterone administration within 30 days 4. Contraindicated to progesterone as following 1) Pregnancy or lactation 2) Abnormal vaginal bleeding 3) Breast mass or history of breast cancer 4) Uncontrolled blood pressure >180/110 mmHg. 5) Diabetes mellitus with complications 6) Diagnosed or history of ischemic heart disease 7) Occlusive vascular diseases 8) Active viral hepatitis, cirrhosis, liver cancer 9) Coagulopathy, deep vein thrombosis, pulmonary embolism

Design outcomes

Primary

MeasureTime frame
Visual acuity Baseline, 1wk, 1mo, 3mo ETDRS chart

Secondary

MeasureTime frame
Color vision, visual field testing Baseline, 1wk, 1mo, 3mo Ishihara test, Humphrey automated perimetry

Countries

Thailand

Contacts

Public ContactSaran Jiranansiri

Phramongkutklao hospital

sarantodtor@gmail.com66870183035

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026